Koyfin Home > Directory > Health Care > Intercept Pharmaceuticals > Altman Z-score

Intercept Pharmaceuticals Altman Z-score Chart (ICPT)

Intercept Pharmaceuticals annual/quarterly Altman Z-score from 2011 to 2020.
  • Intercept Pharmaceuticals Altman Z-score for the quarter ending June 06, 2020 was -2.63 a 40.53% decrease of -1.07 year over year
  • Intercept Pharmaceuticals Altman Z-score for the last 12 months ending June 06, 2020 was -3.06 a 66.10% decrease of -2.02 year over year
  • Intercept Pharmaceuticals Annual Altman Z-score for 2019 was -1.71 a -46.31% increase of 0.79 from 2018
  • Intercept Pharmaceuticals Annual Altman Z-score for 2018 was -2.49 a 13.85% decrease of -0.35 from 2017
  • Intercept Pharmaceuticals Annual Altman Z-score for 2017 was -2.15 a 196.18% decrease of -4.22 from 2016
Other Balance Sheet Metrics:
  • Intercept Pharmaceuticals Total Assets for the quarter ending September 09, 2018 was $557m a 13.04% increase of 73m year over year
  • Intercept Pharmaceuticals Other Liabilities for the quarter ending September 09, 2018 was $5m a -50.16% decrease of -3m year over year
  • Intercept Pharmaceuticals Total Equity for the quarter ending September 09, 2018 was $147m a 88.82% increase of 130m year over year
View Chart On Koyfin

Quarterly ICPT Altman Z-score Data

06/2020-2.63
03/2020-2.51
12/2019-1.73
09/2019-1.57
06/2019-0.41
03/2019-3.27
12/2018-1.97
09/2018-0.27
06/2018-1.22
03/2018-4.77

Annual ICPT Altman Z-score Data

2019-1.71
2018-2.49
2017-2.15
20162.07
201556.12
2014134.11
20135.72
20124.27
2011-6.69